Holdings

The Hartford Healthcare Fund

As of Jul 31, 2026, The Hartford Healthcare Fund reported 75 positions worth US$750M. Largest: Eli Lilly and Company, Johnson & Johnson and Merck & Company, Inc. What it bought and sold, with each filing.

Holdings

Part of
Hartford
Positions
75
Value as reported
US$750M
Holdings as of
Jul 31, 2026
Last filed
Sep 29, 2026
CompanySharesValue as reported% of portfolioChangeAs of
Eli Lilly and Company
NYSE:LLY
80,883US$92.9M12.0%−13,636Jul 31, 2026
Johnson & Johnson
NYSE:JNJ
203KUS$52.1M6.7%+19,101Jul 31, 2026
Merck & Company, Inc.
NYSE:MRK
356KUS$46.3M6.0%−65,362Jul 31, 2026
UnitedHealth Group Incorporated
NYSE:UNH
88,244US$36.6M4.7%−20,768Jul 31, 2026
AbbVie Inc.
NYSE:ABBV
130KUS$32.5M4.2%+23,108Jul 31, 2026
Elevance Health, Inc.
NYSE:ELV
61,615US$23.2M3.0%+21,754Jul 31, 2026
Intuitive Surgical, Inc.
NASDAQ:ISRG
62,861US$22.2M2.9%+5,125Jul 31, 2026
CVS Health Corporation
NYSE:CVS
210KUS$21.9M2.8%−3,284Jul 31, 2026
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
42,701US$20.4M2.6%+1,755Jul 31, 2026
Danaher Corporation
NYSE:DHR
102KUS$19.9M2.6%−7,473Jul 31, 2026
Edwards Lifesciences Corporation
NYSE:EW
223KUS$19.2M2.5%+643Jul 31, 2026
Cencora, Inc.
NYSE:COR
61,017US$19M2.5%+12,445Jul 31, 2026
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
20,444US$15.6M2.0%+1,262Jul 31, 2026
HCA Healthcare, Inc.
NYSE:HCA
36,047US$14.5M1.9%+5,804Jul 31, 2026
Boston Scientific Corporation
NYSE:BSX
310KUS$14.5M1.9%+17,129Jul 31, 2026
Abbott Laboratories
NYSE:ABT
133KUS$14.1M1.8%−91,298Jul 31, 2026
Thermo Fisher Scientific Inc
NYSE:TMO
21,279US$12.2M1.6%−7,269Jul 31, 2026
Agilent Technologies, Inc.
NYSE:A
85,848US$11.9M1.5%+5,976Jul 31, 2026
Amgen Inc.
NASDAQ:AMGN
27,841US$10.7M1.4%NewJul 31, 2026
Biogen Inc.
NASDAQ:BIIB
51,870US$10.5M1.4%+378Jul 31, 2026
Stryker Corporation
NYSE:SYK
29,293US$9.54M1.2%+2,312Jul 31, 2026
GSK plc
LSE:GSK
347KUS$9.01M1.2%−14,230Jul 31, 2026
Medtronic plc.
NYSE:MDT
102KUS$8.67M1.1%−4,484Jul 31, 2026
Centene Corporation
NYSE:CNC
136KUS$8.48M1.1%+91,407Jul 31, 2026
DexCom, Inc.
NASDAQ:DXCM
93,874US$7.83M1.0%−29,324Jul 31, 2026
Incyte Corporation
NASDAQ:INCY
61,086US$7.3M0.95%−841Jul 31, 2026
Cardinal Health, Inc.
NYSE:CAH
30,813US$7.09M0.92%−17,043Jul 31, 2026
United Therapeutics Corporation
NASDAQ:UTHR
13,024US$6.74M0.87%−2,073Jul 31, 2026
STERIS plc (Ireland)
NYSE:STE
28,649US$6.54M0.85%+161Jul 31, 2026
Ucb S.A.
EURONEXT:UCB
23,685US$6.08M0.79%+2,467Jul 31, 2026
AstraZeneca PLC
LSE:AZN
35,800US$6.07M0.79%+20,319Jul 31, 2026
Ascendis Pharma A/S
NASDAQ:ASND
23,901US$5.83M0.75%+999Jul 31, 2026
Bristol-Myers Squibb Company
NYSE:BMY
88,181US$5.76M0.75%No changeJul 31, 2026
Elanco Animal Health Incorporated
NYSE:ELAN
215KUS$5.67M0.73%No changeJul 31, 2026
Cytokinetics, Incorporated
NASDAQ:CYTK
72,039US$5.56M0.72%+9,720Jul 31, 2026
Madrigal Pharmaceuticals, Inc.
NASDAQ:MDGL
11,677US$5.46M0.71%+1,557Jul 31, 2026
Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
104KUS$5.39M0.70%+25,150Jul 31, 2026
Galderma Group AG
SIX:GALD
24,060US$5.24M0.68%+3,659Jul 31, 2026
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
24,864US$5.11M0.66%+6,724Jul 31, 2026
Revolution Medicines, Inc.
NASDAQ:RVMD
26,888US$5.04M0.65%+2,951Jul 31, 2026
Protagonist Therapeutics, Inc.
NASDAQ:PTGX
35,155US$4.8M0.62%−5,533Jul 31, 2026
PTC Therapeutics, Inc.
NASDAQ:PTCT
68,186US$4.64M0.60%+15,637Jul 31, 2026
Heartflow, Inc.
NASDAQ:HTFL
182KUS$4.59M0.59%+34,208Jul 31, 2026
BridgeBio Pharma, Inc.
NASDAQ:BBIO
57,222US$4.58M0.59%+33,218Jul 31, 2026
Arcus Biosciences, Inc.
NYSE:RCUS
160KUS$4.52M0.59%No changeJul 31, 2026
Disc Medicine, Inc.
NASDAQ:IRON
55,907US$4.3M0.56%No changeJul 31, 2026
argenx SE
EURONEXT:ARGX
4,871US$4.16M0.54%−3,533Jul 31, 2026
Encompass Health Corporation
NYSE:EHC
37,246US$4.14M0.54%−10,550Jul 31, 2026
Pharvaris N.V.
NASDAQ:PHVS
123KUS$4.03M0.52%No changeJul 31, 2026
Kymera Therapeutics, Inc.
NASDAQ:KYMR
38,652US$4M0.52%No changeJul 31, 2026
Celldex Therapeutics, Inc.
NASDAQ:CLDX
105KUS$3.99M0.52%+12,809Jul 31, 2026
Dianthus Therapeutics, Inc.
NASDAQ:DNTH
37,237US$3.98M0.52%+2,183Jul 31, 2026
Scholar Rock Holding Corporation
NASDAQ:SRRK
77,842US$3.68M0.48%+7,968Jul 31, 2026
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
160KUS$3.61M0.47%−58,313Jul 31, 2026
Option Care Health, Inc.
NASDAQ:OPCH
151KUS$3.48M0.45%+8,266Jul 31, 2026
Zenas BioPharma, Inc.
NASDAQ:ZBIO
109KUS$3.42M0.44%NewJul 31, 2026
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
31,231US$3.31M0.43%−6,739Jul 31, 2026
Vaxcyte, Inc.
NASDAQ:PCVX
58,543US$3.17M0.41%+15,573Jul 31, 2026
Qiagen N.V.
NYSE:QGEN
74,691US$3.09M0.40%−9,478Jul 31, 2026
Immunome, Inc.
NASDAQ:IMNM
136KUS$3.09M0.40%+18,697Jul 31, 2026
CG Oncology, Inc.
NASDAQ:CGON
40,863US$2.91M0.38%+27,158Jul 31, 2026
Trevi Therapeutics, Inc.
NASDAQ:TRVI
156KUS$2.84M0.37%−25,006Jul 31, 2026
Inspire Medical Systems, Inc.
NYSE:INSP
51,992US$2.61M0.34%No changeJul 31, 2026
Stoke Therapeutics, Inc.
NASDAQ:STOK
89,171US$2.57M0.33%+12,266Jul 31, 2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A
SSE:600276
305KUS$2.32M0.30%−26,506Jul 31, 2026
Kailera Therapeutics, Inc.
NASDAQ:KLRA
133KUS$2.26M0.29%−54,842Jul 31, 2026
Moderna, Inc.
NASDAQ:MRNA
40,629US$2.23M0.29%NewJul 31, 2026
Definium Therapeutics, Inc.
NASDAQ:DFTX
49,500US$2.15M0.28%NewJul 31, 2026
Dyne Therapeutics, Inc.
NASDAQ:DYN
85,300US$2.15M0.28%NewJul 31, 2026
Genfleet Therapeutics (Shanghai), Inc. Class H
HKEX:2595
584KUS$2.06M0.27%No changeJul 31, 2026
Alignment Healthcare, Inc.
NASDAQ:ALHC
131KUS$1.94M0.25%−4,496Jul 31, 2026
ICON plc
NASDAQ:ICLR
11,852US$1.94M0.25%−21,818Jul 31, 2026
Avalyn Pharma Inc.
NASDAQ:AVLN
17,700US$510K0.07%NewJul 31, 2026
Alebund Pharmaceuticals (Jiangsu) Limited Class H
HKEX:9637
85,600US$297K0.04%NewJul 31, 2026
Alamar Biosciences, Inc.
NASDAQ:ALMR
9,100US$231K0.03%No changeJul 31, 2026